66.54
+1.88(+2.91%)
Currency In USD
| Previous Close | 64.66 |
| Open | 64.06 |
| Day High | 67.15 |
| Day Low | 63.94 |
| 52-Week High | 69.33 |
| 52-Week Low | 29.31 |
| Volume | 1.48M |
| Average Volume | 2.08M |
| Market Cap | 7.92B |
| PE | -10.56 |
| EPS | -6.3 |
| Moving Average 50 Days | 60.85 |
| Moving Average 200 Days | 44.41 |
| Change | 1.88 |
If you invested $1000 in Cytokinetics, Incorporated (CYTK) 10 years ago, it would be worth $5,893.71 as of December 04, 2025 at a share price of $66.54. Whereas If you bought $1000 worth of Cytokinetics, Incorporated (CYTK) shares 5 years ago, it would be worth $3,886.68 as of December 04, 2025 at a share price of $66.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy
GlobeNewswire Inc.
Nov 17, 2025 1:10 PM GMT
System of Care to Advance Care for the Most Commonly Inherited Heart Disease SOUTH SAN FRANCISCO, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced its support of a three-year initiative led by the America
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
GlobeNewswire Inc.
Nov 10, 2025 12:30 PM GMT
Three Late Breaking Science Presentations from MAPLE-HCM Provide Additional Data Including Responder Analyses, Patient Reported Outcomes, and Cardiac Biomarkers SOUTH SAN FRANCISCO, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorpora
Cytokinetics to Participate in November Investor Conferences
GlobeNewswire Inc.
Nov 04, 2025 9:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences in November: Stifel 2025 Hea